Cochrane Abstracts
Glutamatergic drugs for schizophrenia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Glutamatergic Drugs for Schizophrenia." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434034/all/Glutamatergic_drugs_for_schizophrenia.
Glutamatergic drugs for schizophrenia. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434034/all/Glutamatergic_drugs_for_schizophrenia. Accessed December 26, 2024.
Glutamatergic drugs for schizophrenia. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434034/all/Glutamatergic_drugs_for_schizophrenia
Glutamatergic Drugs for Schizophrenia [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434034/all/Glutamatergic_drugs_for_schizophrenia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Glutamatergic drugs for schizophrenia
ID - 434034
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434034/all/Glutamatergic_drugs_for_schizophrenia
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
